HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study

Lung Cancer

Volumn 61, Issue 3, 2008, Pages 292-300

  Kucharska Newton, Anna M ^a   Rosamond, Wayne D ^a   Schroeder, Jane C ^a   McNeill, Ann Marie ^b   Coresh, Josef ^c   Folsom, Aaron R ^d  

^a IL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cohort studies; HDL cholesterol; Lipoproteins; Lung neoplasms

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ATHEROSCLEROSIS; CHOLESTEROL, HDL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 50849121989     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.01.015     Document Type: Article

References (32)

1. A.C.S.S.; 2006.
2. Jemal A., Ward E., Hao Y., and Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 294 (2005) 1255-1259
3. Bofetta P., and Trichopoulos D. Cancer of the lung, larynx, and pleura. In: Adami H.O., et al. (Ed). Textbook of cancer epidemiology (2002), Oxford University Press, Inc., Oxford 248-281
4. Patel J.D. Lung cancer in women. J Clin Oncol 23 (2005) 3212-3218
5. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosenberg H.M., Shopland D.R., et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91 (1999) 675-690
6. Shields P.G. Molecular epidemiology of smoking and lung cancer. Oncogene 21 (2002) 6870-6876
7. Siemianowicz K., Gminski J., Stajszczyk M., Wojakowski W., Goss M., Machalski M., et al. Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. Int J Mol Med 6 (2000) 307-311
8. Umeki S. Decreases in serum cholesterol levels in advanced lung cancer. Respiration 60 (1993) 178-181
9. Dessi S., Batetta B., Pulisci D., Spano O., Cherchi R., Lanfranco G., et al. Altered pattern of lipid metabolism in patients with lung cancer. Oncology 49 (1992) 436-441
10. Fiorenza A.M., Branchi A., and Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30 (2000) 141-145
11. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 129 (1989) 687-702
12. 2+-polyethylene glycol precipitation, both with enzymatic cholesterol assay compared with lipid research method. Am J Clin Pathol 78 (1982) 718-723
13. Brown S.A., Hutchinson R., Morrisett J., Boerwinkle E., Davis C.E., Gotto Jr. A.M., et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 13 (1993) 1139-1158
14. McNeill A.M., Katz R., Girman C.J., Rosamond W.D., Wagenknecht L.E., Barzilay J.I., et al. Metabolic syndrome and cardiovascular disease in older people: The Cardiovascular Health Study. J Am Geriatr Soc 54 (2006) 1317-1324
15. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001;285:2486-497.
16. Shahar E., Chambless L.E., Rosamond W.D., Boland L.L., Ballantyne C.M., McGovern P.G., et al. Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 34 (2003) 623-631
17. Nelson W. Theory and applications of hazard plotting for censored failure data. Technometrics 14 (1972) 945-966
18. Aalen O.O. Non parametric inference for a family of counting processes. Ann Stat 6 (1978) 701-726
19. Hess K.R. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14 (1995) 1707-1723
20. Sherwin R.W., Wentworth D.N., Cutler J.A., Hulley S.B., Kuller L.H., and Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 257 (1987) 943-948
21. Boyd N.F., and McGuire V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 82 (1990) 460-468
22. Moorman P.G., Hulka B.S., Hiatt R.A., Krieger N., Newman B., Vogelman J.H., et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 7 (1998) 483-488
23. Furberg A.S., Veierod M.B., Wilsgaard T., Bernstein L., and Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96 (2004) 1152-1160
24. Tall A.R. An overview of reverse cholesterol transport. Eur Heart J 19 Suppl. (1998) A31-A35
25. von Eckardstein A., Hersberger M., and Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 8 (2005) 147-152
26. Hoyer A.P., and Engholm G. Serum lipids and breast cancer risk: a cohort study of 5207 Danish women. Cancer Causes Control 3 (1992) 403-408
27. Gerber M., Cavallo F., Marubini E., Richardson S., Barbieri A., Capitelli E., et al. Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern France. Int J Cancer 42 (1988) 489-494
28. Peto R., Darby S., Deo H., Silcocks P., Whitley E., and Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br Med J 321 (2000) 323-329
29. Tietge U.J., Maugeais C., Lund-Katz S., Grass D., deBeer F.C., and Rader D.J. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice. Arterioscler Thromb Vasc Biol 22 (2002) 1213-1218
30. Esteve E., Ricart W., and Fernandez-Real J.M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24 (2005) 16-31
31. Lamarche B., Rashid S., and Lewis G.F. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 286 (1999) 145-161
32. Maeda K., Noguchi Y., and Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 37 (2003) 283-290